Literature DB >> 27072409

Erratum: Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer.

Jin Sheng, Wenfeng Fang, Juan Yu, Nan Chen, Jianhua Zhan, Yuxiang Ma, Yunpeng Yang, Yan Huang, Hongyun Zhao, Li Zhang.   

Abstract

Entities:  

Year:  2016        PMID： 27072409      PMCID： PMC4829890          DOI： 10.1038/srep23850

Source DB:  PubMed          Journal:  Sci Rep        ISSN： 2045-2322            Impact factor:   4.379


× No keyword cloud information.
The original version of this Article contained an error in the spelling of the author Yan Huang, which was incorrectly given as Yanhuang. This has now been corrected in the PDF and HTML versions of the Article.
  3 in total

1.  Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma.

Authors:  Elly Marcq; Vasiliki Siozopoulou; Jorrit De Waele; Jonas van Audenaerde; Karen Zwaenepoel; Eva Santermans; Niel Hens; Patrick Pauwels; Jan P van Meerbeeck; Evelien L J Smits
Journal:  Oncoimmunology       Date:  2016-11-28       Impact factor: 8.110

Review 2.  PD-L1 expression testing in non-small cell lung cancer.

Authors:  Cristina Teixidó; Noelia Vilariño; Roxana Reyes; Noemí Reguart
Journal:  Ther Adv Med Oncol       Date:  2018-04-11       Impact factor: 8.168

3.  Effect of Primary Systemic Therapy on PD-1, PD-L1, and PD-L2 mRNA Expression in Advanced Breast Cancer.

Authors:  Ramadhan Karsono; Muhammad Al Azhar; Yulia Pratiwi; Fahreza Saputra; Siti Nadliroh; Teguh Aryandono
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.